188 related articles for article (PubMed ID: 22551167)
1. An endoglycosidase with alternative glycan specificity allows broadened glycoprotein remodelling.
Goodfellow JJ; Baruah K; Yamamoto K; Bonomelli C; Krishna B; Harvey DJ; Crispin M; Scanlan CN; Davis BG
J Am Chem Soc; 2012 May; 134(19):8030-3. PubMed ID: 22551167
[TBL] [Abstract][Full Text] [Related]
2. The IgG-specific endoglycosidases EndoS and EndoS2 are distinguished by conformation and antibody recognition.
Sudol ASL; Crispin M; Tews I
J Biol Chem; 2024 May; 300(5):107245. PubMed ID: 38569940
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into the mechanisms and specificities of IgG-active endoglycosidases.
Du JJ; Klontz EH; Guerin ME; Trastoy B; Sundberg EJ
Glycobiology; 2020 Mar; 30(4):268-279. PubMed ID: 31172182
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of Streptococcus pyogenes EndoS, an immunomodulatory endoglycosidase specific for human IgG antibodies.
Trastoy B; Lomino JV; Pierce BG; Carter LG; Günther S; Giddens JP; Snyder GA; Weiss TM; Weng Z; Wang LX; Sundberg EJ
Proc Natl Acad Sci U S A; 2014 May; 111(18):6714-9. PubMed ID: 24753590
[TBL] [Abstract][Full Text] [Related]
5. Fragments of bacterial endoglycosidase s and immunoglobulin g reveal subdomains of each that contribute to deglycosylation.
Dixon EV; Claridge JK; Harvey DJ; Baruah K; Yu X; Vesiljevic S; Mattick S; Pritchard LK; Krishna B; Scanlan CN; Schnell JR; Higgins MK; Zitzmann N; Crispin M
J Biol Chem; 2014 May; 289(20):13876-89. PubMed ID: 24668806
[TBL] [Abstract][Full Text] [Related]
6. EndoS from Streptococcus pyogenes is hydrolyzed by the cysteine proteinase SpeB and requires glutamic acid 235 and tryptophans for IgG glycan-hydrolyzing activity.
Allhorn M; Olsén A; Collin M
BMC Microbiol; 2008 Jan; 8():3. PubMed ID: 18182097
[TBL] [Abstract][Full Text] [Related]
7. One-pot enzymatic glycan remodeling of a therapeutic monoclonal antibody by endoglycosidase S (Endo-S) from Streptococcus pyogenes.
Tong X; Li T; Orwenyo J; Toonstra C; Wang LX
Bioorg Med Chem; 2018 Apr; 26(7):1347-1355. PubMed ID: 28789910
[TBL] [Abstract][Full Text] [Related]
8. EndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans.
Sjögren J; Cosgrave EF; Allhorn M; Nordgren M; Björk S; Olsson F; Fredriksson S; Collin M
Glycobiology; 2015 Oct; 25(10):1053-63. PubMed ID: 26156869
[TBL] [Abstract][Full Text] [Related]
9. Insights into substrate recognition and specificity for IgG by Endoglycosidase S2.
Aytenfisu AH; Deredge D; Klontz EH; Du J; Sundberg EJ; MacKerell AD
PLoS Comput Biol; 2021 Jul; 17(7):e1009103. PubMed ID: 34310592
[TBL] [Abstract][Full Text] [Related]
10. EndoS2 is a unique and conserved enzyme of serotype M49 group A Streptococcus that hydrolyses N-linked glycans on IgG and α1-acid glycoprotein.
Sjögren J; Struwe WB; Cosgrave EF; Rudd PM; Stervander M; Allhorn M; Hollands A; Nizet V; Collin M
Biochem J; 2013 Oct; 455(1):107-18. PubMed ID: 23865566
[TBL] [Abstract][Full Text] [Related]
11. Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions.
Huang W; Giddens J; Fan SQ; Toonstra C; Wang LX
J Am Chem Soc; 2012 Jul; 134(29):12308-18. PubMed ID: 22747414
[TBL] [Abstract][Full Text] [Related]
12. EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG.
Collin M; Olsén A
EMBO J; 2001 Jun; 20(12):3046-55. PubMed ID: 11406581
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for the recognition of complex-type N-glycans by Endoglycosidase S.
Trastoy B; Klontz E; Orwenyo J; Marina A; Wang LX; Sundberg EJ; Guerin ME
Nat Commun; 2018 May; 9(1):1874. PubMed ID: 29760474
[TBL] [Abstract][Full Text] [Related]
14. Glycoengineering of antibody (Herceptin) through yeast expression and in vitro enzymatic glycosylation.
Liu CP; Tsai TI; Cheng T; Shivatare VS; Wu CY; Wu CY; Wong CH
Proc Natl Acad Sci U S A; 2018 Jan; 115(4):720-725. PubMed ID: 29311294
[TBL] [Abstract][Full Text] [Related]
15. Sugar-free antibodies--the bacterial solution to autoimmunity?
Allhorn M; Collin M
Ann N Y Acad Sci; 2009 Sep; 1173():664-9. PubMed ID: 19758213
[TBL] [Abstract][Full Text] [Related]
16. Generation and Comparative Kinetic Analysis of New Glycosynthase Mutants from Streptococcus pyogenes Endoglycosidases for Antibody Glycoengineering.
Tong X; Li T; Li C; Wang LX
Biochemistry; 2018 Sep; 57(35):5239-5246. PubMed ID: 30102520
[TBL] [Abstract][Full Text] [Related]
17. Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins.
Collin M; Olsén A
Infect Immun; 2001 Nov; 69(11):7187-9. PubMed ID: 11598100
[TBL] [Abstract][Full Text] [Related]
18. Generation of a Mutant Mucor hiemalis Endoglycosidase That Acts on Core-fucosylated N-Glycans.
Katoh T; Katayama T; Tomabechi Y; Nishikawa Y; Kumada J; Matsuzaki Y; Yamamoto K
J Biol Chem; 2016 Oct; 291(44):23305-23317. PubMed ID: 27629418
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of antibody-specific deglycosylation and immune evasion by Streptococcal IgG-specific endoglycosidases.
Trastoy B; Du JJ; Cifuente JO; Rudolph L; García-Alija M; Klontz EH; Deredge D; Sultana N; Huynh CG; Flowers MW; Li C; Sastre DE; Wang LX; Corzana F; Mallagaray A; Sundberg EJ; Guerin ME
Nat Commun; 2023 Mar; 14(1):1705. PubMed ID: 36973249
[TBL] [Abstract][Full Text] [Related]
20. Glycosynthases enable a highly efficient chemoenzymatic synthesis of N-glycoproteins carrying intact natural N-glycans.
Huang W; Li C; Li B; Umekawa M; Yamamoto K; Zhang X; Wang LX
J Am Chem Soc; 2009 Feb; 131(6):2214-23. PubMed ID: 19199609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
